Category: Stock Market

  • Why is everyone talking about Flight Centre, Air New Zealand and Virgin Australia shares on Friday?

    Surprised child reading all about ASX 200 shares in a newspaper.

    Flight Centre Travel Group Ltd (ASX: FLT), Air New Zealand Ltd (ASX: AIZ), and Virgin Australia Holdings Ltd (ASX: VGN) shares are turning heads on Friday.

    In morning trade today, two of the well-known ASX shares are outpacing the 0.2% gains posted by the All Ordinaries Index (ASX: XAO), while one is trailing the benchmark.

    Here’s what’s catching investor interest.

    Virgin Australia shares rise on renewed dividend

    Virgin Australia shares are up 1.1% at the time of writing, swapping hands for $2.84 apiece.

    This follows the release of the ASX 300 airline’s full-year FY 2026 results.

    Highlights included a 13.4% year-on-year increase in underlying earnings before interest and tax (EBIT) to $753 million.

    And on the bottom line, Virgin Australia shares look to be getting support today from the airline’s 21.9% increase in underlying net profit after tax (NPAT) to $404 million.

    The company also issued its first dividend since relisting on the ASX in June 2025. Management declared a fully-franked dividend of 7.6 cents per share.

    Air New Zealand shares sink on net loss

    Air New Zealand also released its FY 2026 results today.

    But unlike Virgin Australia shares, Air New Zealand shares are down 0.8% following the release, trading for 32.3 cents each.

    On the positive side of the ledger, the Kiwi airline reported a 3.9% year-on-year increase in revenue to NZ$7.0 billion.

    However, operating cash flow of NZ$819 million was down 12.8% from FY 2025.

    And the company posted a net loss after tax of NZ$242 million.

    Much of the pressure has come from surging jet fuel costs amid the ongoing Middle East conflict.

    Air New Zealand management noted, “The Middle East conflict increased fuel cost by an estimated $328 million compared to what we expected going into the second half, and by $205 million after hedging.”

    Flight Centre shares lift amid board shakeup

    Joining Air New Zealand and Virgin Australia shares in creating a buzz today, we find Flight Centre.

    After reporting its FY 2026 results on Wednesday, today the ASX 200 travel stock announced some major leadership changes.

    Flight Centre revealed that Gareth Turner will join the board as an independent non-executive director. Turner will succeed Rob Baker, a 13-year veteran of the company’s board.

    Commenting on Turner’s appointment, Flight Centre chair Gary Smith said:

    Gareth brings deep financial and commercial experience across the technology, telecommunications and travel and tourism sectors, along with a strong track record as a CFO.

    The board looks forward to drawing on his expertise as our company continues to evolve and targets near-term and longer-term growth opportunities.

    Flight Centre shares are up 0.6% at the time of writing, trading for $12.26 apiece.

    The post Why is everyone talking about Flight Centre, Air New Zealand and Virgin Australia shares on Friday? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Air New Zealand right now?

    Before you buy Air New Zealand shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Air New Zealand wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Flight Centre Travel Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Virgin Australia shareholders are getting a dividend. Here’s how much

    A smiling boy holds a toy plane aloft while a girl watches on from a car near an airport runway.

    Virgin Australia Holdings Ltd (ASX: VGN) shares are in the green on Friday after the airline released its FY26 results.

    At the time of writing, the Virgin share price is up 2.14% to $2.87.

    There were plenty of numbers for investors to unpack, with earnings and revenue both moving higher during the year.

    However, income investors may be paying particularly close attention to one part of the result.

    Virgin Australia has declared its first dividend since returning to the ASX last year.

    So, how much will shareholders receive?

    Virgin Australia declares a fully-franked dividend

    Virgin has declared a fully-franked dividend of 7.6 cents per share for FY26.

    It’s a notable moment for shareholders, with this being the airline’s first dividend since returning to the ASX last year.

    At the current share price of $2.87, the payment works out to a yield of almost 3% before franking credits.

    The company said the dividend follows its capital allocation framework, which focuses on keeping the balance sheet strong and funding the business first.

    Virgin Australia finished FY26 with net debt of $1.2 billion and leverage of 0.9 times underlying EBITDA, below its target range of 1 to 2 times.

    It also had $1.84 billion in cash, cash equivalents, and term deposits at the end of June.

    When will Virgin Australia pay its dividend?

    Virgin shares are locked in to trade ex-dividend on 14 September.

    The record date will follow on 15 September, with the dividend due to be paid one month later on 15 October.

    And because it is fully franked, shareholders can also benefit from franking credits.

    What did Virgin Australia report?

    The airline delivered a stronger result in FY26, with underlying EBIT rising 13.4% to $753 million.

    Underlying net profit after tax (NPAT) increased 21.9% to $404 million, while statutory NPAT rose 4.7% to $501 million.

    Underlying revenue increased 8.1% to $6.28 billion, helped by strong customer demand and growth across both the airline and Velocity businesses.

    Virgin Australia’s airline segment reported underlying EBIT of $616 million, up 15.2%, while Velocity EBIT increased 12.3% to $143 million.

    Operating cash flow also came in at $1.3 billion for the year.

    What’s next on the horizon?

    Seeing dividends return is another positive for shareholders since Virgin Australia relisted.

    Looking ahead, the company said demand and forward bookings remain strong, although first-half FY27 underlying EBIT is expected to be relatively flat.

    Domestic capacity is expected to fall by around 3% during the half, while revenue per available seat kilometre is forecast to rise 6% to 8%.

    If earnings keep moving in the right direction, shareholders could have more dividends to look forward to.

    The post Virgin Australia shareholders are getting a dividend. Here’s how much appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Virgin Australia right now?

    Before you buy Virgin Australia shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Virgin Australia wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • How high do brokers think Bubs Australia shares will go?

    A baby's eyes open wide in surprise as it sucks on a milk bottle.

    Shares in Bubs Australia Ltd (ASX: BUB) are down almost 50% over the past 12 months, but if the brokers are to be believed, the shares are about to make a comeback.

    Both Bell Potter and Shaw and Partners have released new research reports on the baby formula company, and each is predicting solid share price gains.

    I’ll get to the specifics of their share price targets shortly. First, let’s look at the company’s recent full-year report.

    Profits on the rise

    Bubs said in its report released this week that full-year revenue had increased 9.2% to $111.9 million, while underlying EBITDA came in at $5.3 million, up from $2.1 million.

    Bubs Chief Executive Officer Joe Coote said of the result:

    FY26 marked important progress against our growth strategy, delivering revenue growth of 9% and strengthening the foundations for future growth. This was driven by continued momentum in the United States, where revenue increased 24% as we expanded distribution to more than 10,000 stores across targeted retail formats. During the year we rebuilt inventory levels, expanded distribution channels, launched adjacent products, increased brand investment and strengthened our leadership team to support future growth. This progress was achieved despite a challenging operating environment, with changing tariff policies, geopolitical disruption and evolving regulatory requirements increasing supply chain costs and affecting product availability, particularly in the second half.

    The company said it expected improved momentum in the first half of FY27, with strong growth expected in the US, growth expected in China supported by expanded distribution and marketing, and continued marketing investment in Australia to accelerate recovery.

    The company added:

    Gross margin is expected to rebound, with working capital positioned to support the anticipated growth.

    Bubs Australia shares looking cheap

    Shaw and Partners said the results were largely in line with expectations, and the current year would be driven by growth in the US.

    They said:

    Our key investment thesis remains centred on the US business, where revenue grew 24% to $65.8 million and distribution expanded to over 10,000 stores, while management expects growth and margin recovery in FY27 as regulatory and tariff headwinds ease and permanent FDA approval progresses. Following the result, we have reduced our DCF valuation from $0.16/s to $0.15/s, reflecting forecast revisions and model roll-forward, but maintained our buy rating given the forecast 74% total shareholder return potential and confidence in the company’s medium-term growth outlook.

    Bell Potter has a price target of 13.5 cents on Bubs shares, compared to 8.6 cents currently.

    Bubs is valued at $76.9 million.

    The post How high do brokers think Bubs Australia shares will go? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Bubs Australia right now?

    Before you buy Bubs Australia shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Bubs Australia wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Are DroneShield shares a buy after dropping almost 50% in 2026?

    Woman and man at work looking at data on a tablet at work.

    DroneShield Ltd (ASX: DRO) shares have had a rough year.

    The stock is down almost 50% since the start of 2026, even though the underlying business is still growing strongly.

    For patient investors comfortable with plenty of volatility, I think that disconnect is becoming attractive.

    Growth is still there

    DroneShield’s latest half-year result was a little softer than I had hoped in some areas, particularly given the expectations that had built around the company.

    But I do not think the bigger picture has changed.

    First-half revenue reached $125.8 million, up 74% on the prior corresponding period. Recurring revenue also grew strongly, although it remains a relatively small part of the overall business.

    That tells me demand for DroneShield’s counter-drone technology is still expanding quickly.

    The company operates in a market that has become much more important in recent years. Drones are playing a growing role in modern warfare, while governments are also looking for better ways to protect military bases, airports, infrastructure, and other sensitive locations.

    I think spending on counter-drone technology could remain elevated for a long time.

    I am looking much further ahead

    The main reason I would consider buying after the fall is that I think DroneShield could be a considerably larger company in 10 years.

    It is still building out manufacturing capacity, expanding internationally, and investing in new hardware and software.

    That is important because counter-drone technology will not stand still. Threats will keep changing, so customers will need systems that can be upgraded and improved rather than equipment that quickly becomes outdated.

    DroneShield has spent years specialising in this field, and I think that focus gives it a chance to remain relevant as the market develops.

    If it keeps winning larger contracts and builds deeper relationships with defence and security customers, today’s business could eventually look quite small.

    The share price will probably remain volatile

    I would not treat the 50% decline as proof that DroneShield shares are automatically cheap.

    DroneShield remains a high-risk growth investment and trades on a very high P/E ratio.

    Defence contracts can arrive unevenly, procurement processes can take longer than expected, and competition is increasing as more companies target the counter-drone market.

    The company is also investing heavily for future growth, which means results may not progress neatly from one period to the next.

    That is why I would keep any position relatively small and only invest money I was prepared to leave in the shares through potentially sharp moves in either direction.

    Foolish takeaway

    Yes, I think DroneShield shares are worth considering after falling around 50% in 2026.

    The latest performance was not perfect, but the company is still delivering strong growth in a market with substantial long-term potential.

    For investors willing to ride out the volatility, I think the current weakness could prove to be an opportunity if DroneShield becomes the much larger defence technology business I believe it can be over the next decade.

    The post Are DroneShield shares a buy after dropping almost 50% in 2026? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in DroneShield right now?

    Before you buy DroneShield shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and DroneShield wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Grace Alvino has positions in DroneShield. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended DroneShield. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Dicker Data delivers record H1 FY26 profit and lifts full-year guidance

    An investor looks happy holding a finger to his computer screen while holding a coffee cup in a home office scenario.

    The Dicker Data Ltd (ASX: DDR) share price is in focus today after the company reported a strong H1 FY26, with gross revenue climbing 14.2% to $2,100.9 million and net profit after tax up 54.1% to $60.7 million.

    What did Dicker Data report?

    • Gross revenue reached $2,100.9 million, up 14.2% versus the prior corresponding period (pcp)
    • Gross profit increased 23.0% to $205.6 million, with gross profit margin at 9.8%
    • EBITDA rose 37.3% to $103.5 million
    • Net operating profit before tax grew 50.1% to $86.4 million
    • Net profit after tax jumped 54.1% to $60.7 million
    • Recurring gross software sales up 20.7% to $600 million
    • FY26 guidance: Gross revenue of $4.3–$4.4 billion and PBT of $162–$165 million

    What else do investors need to know?

    Australian operations drove much of the growth, with gross revenue up 18.3% to $1,831.5 million and gross profit rising 29.0%. This result helped offset softer trading and lower profit in New Zealand, where gross revenue was down 7.6% amid currency headwinds.

    Software and Advanced Solutions were standout performers, growing 18% and 16.9% respectively, thanks to continued demand in cloud, cybersecurity, AI infrastructure and data centre investments. Dicker Data also expanded its vendor portfolio, signing new partners in areas like AI, cybersecurity, and data management to help meet evolving technology needs.

    The company also achieved record first-half AI-related sales and bookings, with an invoiced value exceeding $50 million, supporting its position as a key enabler in the IT channel.

    What did Dicker Data management say?

    Executive Chair and Managing Director Fiona Brown said:

    The Company delivered a strong first half result, with gross revenue surpassing $2.1 billion. This performance reflects the continued strength of our operating model, disciplined execution across the business, and the ability of our teams to capture opportunities emerging from major technology refresh cycles, AI infrastructure investment and sustained demand across software and cybersecurity.

    What’s next for Dicker Data?

    Looking ahead, Dicker Data expects robust demand to continue through the rest of FY26, underpinned by digital transformation, ongoing technology refreshes, and broader adoption of AI solutions. Management expects growth in data centre, software, and AI-related projects to support H2 FY26, though end-point solutions growth may moderate and higher component prices could impact margins in the second half.

    The company’s FY26 guidance is for group gross revenue between $4.3 billion and $4.4 billion, and PBT of $162 million to $165 million. Dicker Data says its diversified vendor portfolio and strong industry fundamentals position it well for continued momentum.

    Dicker Data share price snapshot

    Over the past 12 months, Dicker Data shares have risen 37%, far outpacing the All Ordinaries Index (ASX: XAO).

    View Original Announcement

    The post Dicker Data delivers record H1 FY26 profit and lifts full-year guidance appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Dicker Data right now?

    Before you buy Dicker Data shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Dicker Data wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Dicker Data. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

  • Harvey Norman lifts profit and dividend in FY26 earnings result

    Happy couple doing online shopping.

    The Harvey Norman Holdings Ltd (ASX: HVN) share price is in focus today after the company reported a 4.9% increase in statutory profit before tax to $790.29 million and announced a fully-franked final dividend of 13.0 cents per share.

    What did Harvey Norman report?

    • Total system sales revenue up 3.1% to $9.64 billion
    • Earnings before interest, tax, depreciation & amortisation (EBITDA) rose 5.0% to $1.18 billion
    • Statutory profit before tax increased 4.9% to $790.29 million
    • Underlying profit before tax (excl. AASB 16, property revals, penalty) up 10.9% to $654.69 million
    • Basic earnings per share grew 2.0% to 42.41 cents
    • Fully-franked dividend lifted 3.8% to 27.5 cents per share for FY26

    What else do investors need to know?

    The company highlighted strong performance from its international operations, with overseas company-operated retail profit before tax jumping 23.4% to $135.72 million. Harvey Norman continued its international expansion, particularly in the UK, where its platform is being scaled for long-term growth.

    Asset strength remains a key feature, with total assets increasing 5.7% to $8.85 billion. Operating cash flows were robust at $537.22 million, underpinning ongoing investments, dividend payments, and future initiatives.

    What did Harvey Norman management say?

    The company’s chair, Gerry Harvey, commented:

    FY26 delivered growth in operating earnings, continued international expansion and strong franchise profitability. With total assets approaching $9 billion, net assets approaching $5 billion, substantial property ownership and low gearing, we remain well positioned to deliver long-term sustainable growth for our shareholders.

    What’s next for Harvey Norman?

    Harvey Norman is focused on leveraging its growing international presence, especially in established markets like New Zealand, Asia, and Europe. Management expects positive momentum to continue as the company opens new stores, invests in Next Gen-AI product categories, and maintains attention to cost management.

    With a strong asset-backed balance sheet and conservative gearing, the business aims to fund further expansions while supporting long-term value creation for shareholders.

    Harvey Norman share price snapshot

    The Harvey Norman share price is underperforming the S&P/ASX 200 index (ASX: XJO) with a decline of around 27% over the past 12 months.

    View Original Announcement

    The post Harvey Norman lifts profit and dividend in FY26 earnings result appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the ‘five best ASX stocks’ for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Harvey Norman. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

  • WAM Capital trims FY27 dividend after portfolio setback in FY26

    A woman sits at a computer with a quizzical look on her face with eyerows raised while looking into a computer, as though she is resigned to some not pleasing news.

    The WAM Capital Ltd (ASX: WAM) share price is in focus today after reporting a 10.5% decline in its investment portfolio for FY2026 and announcing a maintained final dividend of 7.75 cents per share, partially franked at 60%.

    What did WAM Capital report?

    • Full year FY2026 dividend of 15.5 cents per share, partially franked at 60%, maintained
    • Final dividend of 7.75 cents per share, payable 21 October 2026
    • Operating loss after tax of $125.9 million (FY2025: profit of $219.6 million)
    • Investment portfolio declined 10.5% in FY2026, underperforming key ASX indices
    • FY2027 dividend target reduced to 8.0 cents per share to preserve capital
    • Pre-tax net tangible assets (NTA) at $1.22 per share at 30 June 2026

    What else do investors need to know?

    The Board’s decision to cut the FY2027 dividend target to 8.0 cents per share comes after years of paying out more in dividends than was earned, drawing down the profits reserve from $1.48 per share to just 5.6 cents per share after the latest payout. The reduction aims to protect WAM Capital’s capital base and rebuild its profits reserve.

    In FY2026, WAM Capital’s portfolio underperformed compared to the broader S&P/ASX All Ordinaries Accumulation Index (up 5.7%) and S&P/ASX Small Ordinaries Accumulation Index (up 8.1%). The main challenges were sector positioning and tough conditions for small-cap industrials, as larger companies and AI beneficiaries attracted most investor attention.

    WAM Capital remains focused on a diversified portfolio, with notable holdings in Artrya Limited, GemLife Communities, Aussie Broadband, and Maas Group. The investment team has increased cash holdings (11.5% of the portfolio) and repositioned assets looking for better returns in FY2027.

    What did WAM Capital management say?

    Chairman Geoff Wilson AO said:

    Since FY2020, the Board has maintained WAM Capital’s full year dividend at 15.5 cents per share. Over that period, the dividends paid by the Board exceeded the profits generated, drawing down the Company’s accumulated profits reserve. Maintaining the dividend at 15.5 cents per share is no longer sustainable with the profits reserve available.

    We recognise the impact a reduction in the FY2027 full year dividend target to 8.0 cents per share will have on shareholders. The FY2027 target is intended to rebuild the profits reserve, preserve the Company’s capital base and place WAM Capital in a stronger position to deliver sustainable income and capital growth for shareholders.

    What’s next for WAM Capital?

    The Board has set a more sustainable FY2027 dividend target, aiming for 8.0 cents per share, split evenly between interim and final dividends, still partially franked at 60%. Achieving this will depend on generating additional profits through positive portfolio performance in FY2027, so the dividend target is not a formal forecast or guarantee.

    Management is optimistic about the potential for recovery, particularly for undervalued smaller companies, as interest rates stabilise and market conditions improve. WAM Capital plans to maintain its active, diversified approach and is positioned to benefit if conditions for small-to-mid-cap stocks pick up.

    View Original Announcement

    The post WAM Capital trims FY27 dividend after portfolio setback in FY26 appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Wam Capital right now?

    Before you buy Wam Capital shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Wam Capital wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Aussie Broadband. The Motley Fool Australia has recommended Aussie Broadband. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

  • 2 ASX small-cap stocks Bell Potter thinks could return 130% to 200%

    A woman in a red dress holding up a red graph.

    Small-cap stocks with growth potential can deliver great share price gains, and Bell Potter thinks they’ve identified two such companies.

    They’ve released research reports this week into two companies in the healthcare sector, and are predicting solid gains for both.

    Let’s see who they like.

    Lumos Diagnostics Ltd (ASX: LDX)

    This diagnostic technology company recently reported full-year revenue of US$13.2 million, up 6% on the previous year, and an adjusted EBITDA loss of US$2.8 million, which was a 19% improvement.

    The company said it was a “landmark year underpinned by significant regulatory, commercial, and operational achievements that have positioned the Company for future growth”.

    The company went on to say:

    The year was highlighted by the execution of a transformational six-year U.S. distribution agreement with PHASE Scientific with a value of US$317 million, achievement of U.S. FDA CLIA waiver status for FebriDx, and securing nationwide Medicare reimbursement recognition across all U.S. Medicare Administrative Contractors (MACs). These milestones materially expanded the addressable market opportunity for FebriDx by more than 15 times to over US$1.0 billion per annum and established the foundations for large-scale commercial adoption in the U.S.

    The company said FY27 will be about converting the regulatory and commercial milestones achieved in FY26 into sustained revenue growth.

    Bell Potter agreed, saying the commercial execution of the FebriDx rollout would be the focus.

    The broker is expecting Lumos to hit breakeven in FY29.

    Bell Potter has a price target of 25 cents on Lumos, compared to the current price of 10 cents. Lumos Diagnostics is valued at $94.5 million.

    Trajan Group Ltd (ASX: TRJ)

    This analytical science company delivered second-half EBITDA of $8.1 million, up from $5 million in the first half of the year, but overall full-year earnings were down 14.7%.

    Chief Executive Officer Stephen Tomisich said of the result:

    FY26 was a year of two halves. While the first quarter created a difficult starting point for the year, the business recovered operationally from Q2 onward, and we delivered a materially stronger second half result. The benefits of Project Neptune and other operational initiatives became increasingly evident in H2, with improved gross margins, stronger nEBITDA and better cost control across the Group. These gains were partly masked in the reported result by the appreciation of the Australian dollar against key trading currencies.

    The company’s guidance for the current year is for mid-single-digit organic revenue growth in FY27 and double-digit EBITDA growth.

    Bell Potter said the company “is trading at an extremely deep discount, but it will need to turnaround earnings momentum to shift investor sentiment”.

    Bell Potter has a price target of 50 cents on Trajan shares compared to 16.5 cents currently.

    The post 2 ASX small-cap stocks Bell Potter thinks could return 130% to 200% appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Lumos Diagnostics right now?

    Before you buy Lumos Diagnostics shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Lumos Diagnostics wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Solstice Minerals extends deep, high-grade copper-gold zones at Nanadie

    Woman with gold nuggets on her hand.

    The Solstice Minerals Ltd (ASX: SLS) share price is in focus after the company reported outstanding deep drilling results at its 100%-owned Nanadie Copper-Gold Project in Western Australia, including a 722.3-metre intercept grading 0.44% copper and 0.13g/t gold.

    What did Solstice Minerals report?

    • Confirmed a total intercept of 722.3m @ 0.44% Cu, 0.13g/t Au from hole NANRCD005, extending mineralisation over 500m below the current Mineral Resource boundary.
    • Significant high-grade sections include 28m @ 1.31% Cu, 0.30g/t Au and 43.3m @ 0.91% Cu, 0.35g/t Au at depth.
    • Current Mineral Resource Estimate (MRE) stands at 40.4 million tonnes @ 0.4% Cu, 0.1g/t Au, with the new results indicating strong potential for expansion.
    • Assays are pending from a further 14 diamond holes and over 20 Reverse Circulation (RC) holes.
    • Solstice holds $45 million in cash and has no debt, providing a solid balance sheet for continued exploration.
    • The Nanadie project sits fully within a granted Mining Lease, with step-up drilling programs underway.

    What else do investors need to know?

    Solstice Minerals’ drilling campaign is expanding the known copper-gold system well beyond previous boundaries, with both scale and grade persisting at depth. The close match between laboratory assays and previously logged visible copper sulphide zones is increasing confidence in Solstice’s geological model and upcoming drill targets.

    The company has invested in expanding its exploration camp and core processing facilities, and expects to have multiple rigs operating for the remainder of the year. Drilling results from the nearby Stark Prospect and unexplored extensions north of Nanadie are also expected to flow through in coming months.

    What did Solstice Minerals management say?

    Nick Castleden, CEO and Managing Director, said:

    NANRCD005 is an extraordinary drillhole that marks another defining moment in the rapidly unfolding story at Nanadie. The combined 722.3m @ 0.44% Cu, 0.13g/t Au intercept – inclusive of all post-mineral dykes and low-grade zones – provides definitive evidence that the deposit will continue to deliver scale and grade way beyond the current MRE limits. Within that broad mineralised envelope, we are seeing multiple substantial higher-grade zones such as 28m @ 1.31% Cu, 0.3g/t Au and 43.3m @ 0.91% Cu, 0.35g/t Au – showing that grade as well as scale persist at depth.

    What’s next for Solstice Minerals?

    Solstice is stepping up both RC and diamond drilling to test for further extensions of the Nanadie deposit, targeting expansion of its current Mineral Resource. With a second RC rig due onsite and a large volume of assay results still pending, investors can expect a steady news flow through the remainder of 2026.

    The business is also planning to drill new prospects at Stark and to test previously untested targets along the broader geological corridor. The focus will remain on growing the scale and grade of the copper-gold system and progressing towards updated resources and potential development studies.

    Solstice Minerals share price snapshot

    Over the past 12 months, Solstice Minerals shares have surged more than 600%, significantly outpacing the All Ordinaries Index (ASX: XAO).

    View Original Announcement

    The post Solstice Minerals extends deep, high-grade copper-gold zones at Nanadie appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Solstice Minerals right now?

    Before you buy Solstice Minerals shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Solstice Minerals wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

  • Imricor Medical Systems and Philips launch MR-guided cardiac interventions lab

    Shot of a young scientist using a digital tablet while working in a lab.

    The Imricor Medical Systems Inc (ASX: IMR) share price is in focus today after the company announced the commercial launch of its Interventional MR (iMR) lab solution in collaboration with global imaging leader Philips. This new combined solution is immediately available in CE-marked markets and is designed to support MR-guided cardiac interventions.

    What did Imricor Medical Systems report?

    • Commercial launch of a combined iMR lab solution with Philips.
    • The solution integrates Philips’ 1.5T BlueSeal MR platform with Imricor’s NorthStar®, Advantage-MR®, and other systems.
    • Includes Imricor’s single-use catheters and interventional tools for cardiac procedures.
    • Available immediately in CE-marked markets; select configurations in the US now and more pending regulatory approval.
    • Scalable platform for potential expansion into new procedures and clinical areas.

    What else do investors need to know?

    The launch builds on Imricor’s longstanding partnership with Philips, which began in 2012 with joint technology development. The iMR lab solution is designed specifically for cardiac electrophysiology and other interventional cardiac procedures, using MR-guided imaging for improved care.

    This innovative, purpose-built approach aims to move MR imaging technology directly into the procedure room, making advanced interventions safer and more effective. The collaboration positions Imricor alongside a major industry player, broadening its reach and potential customer base.

    What’s next for Imricor Medical Systems?

    Imricor plans to showcase the new iMR lab solution at the ESC Congress 2026 in Munich. The company expects further configurations to be launched in the United States and other geographies as regulatory clearances are achieved.

    Management sees this launch as a foundation for future growth, with ambitions to expand the platform into new clinical areas beyond cardiac electrophysiology. The partnership with Philips could pave the way for increased adoption of MR-guided interventions globally.

    Imricor Medical Systems share price snapshot

    Over the past 12 months, Imricor shares have risen 39%, outperforming the All Ordinaries Index (ASX: XAO).

    View Original Announcement

    The post Imricor Medical Systems and Philips launch MR-guided cardiac interventions lab appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Imricor Medical Systems right now?

    Before you buy Imricor Medical Systems shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Imricor Medical Systems wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.